(Q82726101)

English

Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)

scientific article published on 03 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Stefan Kommoss

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Andreas du Bois

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dietmar Schmidt

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R Parwaresch

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jacobus Pfisterer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Friedrich Kommoss

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

3 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

103

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

67-71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Prognostic value of MIB-1 in neuroendocrine tumours of the lung

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

The use of avidin-biotin interaction in immunoenzymatic techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Ki67 antigen immunostaining (MIB 1 monoclonal antibody) in serous ovarian tumors: index of proliferative activity with prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Prognostic significance of Ki-67 antigen immunostaining (MIB-1 monoclonal antibody) in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: Correlation with dna flow cytometry, biochemical receptor assay, and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Immunohistochemical determination of tumour growth fraction in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Transforming growth factor-beta3 protection of epithelial cells from cycle-selective chemotherapy in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.01.037

7 January 2021

Identifiers

10.1016/J.YGYNO.2006.01.037

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16516280%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82726101&oldid=1751468006"